These findings provide further insights into novel epigenetic mechanisms by which chronic IHR leads to adverse consequences in OSA, and opens the possibility of using HDAC1 inhibitor in preventing the morbidities and mortality. This evidence concerns the gene HDAC1 and obstructive sleep apnea syndrome.